News
23andMe Re-Opens Data Auction With $305 Million Bid From Former CEO
After a brief court dispute, 23andMe and all its assets are up for auction once again. The second time around, former CEO Amy Wojcicki has started out hot with an opening bid nearly $50 million higher than the previous auction’s winner.
Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...
Me has a path to a higher purchase price than the $256 million offered by biotech giant Regeneron after the genetic-testing ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The judge overseeing the bankruptcy of 23andMe questioned the limits proposed for a second auction that is designed to push ...
The move marks a turning point in 23andMe’s tumultuous decline. Founded in 2006 by Wojcicki, the company initially gained traction with its saliva-based ancestry kits and went public in 2021. By the ...
A class action lawsuit, resignations, and layoffs plagued 23andMe, which filed for Chapter 11 in March. Biotech company Regeneron is buying the DNA testing startup's assets for $256 million.
Bankrupt genetic analysis company 23andMe will hold a second auction for its cache of DNA data with an opening bid of $305 ...
The founder of 23andMe, Anne Wojcicki, has asked a federal bankruptcy court judge to reopen an auction for the genetic ...
Did you spit in a tube for 23andMe? If so, your genetic data may soon be handed over to a new company — Regeneron. Just four years ago, when 23andMe went public, the company was valued at $6 ...
In trying to lead before the system could follow, 23andMe outpaced the very guardrails that might have legitimized it”: A ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback